Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
IL-18 VARIANT POLYPEPTIDES
Document Type and Number:
WIPO Patent Application WO/2024/051728
Kind Code:
A1
Abstract:
Provided are interleukin 18 (IL-18) variant polypeptides that comprise mutation (s) at one or more of G3, E6, D54, and N91, wherein amino acid positions are relative to a wild-type human IL-18 set forth in SEQ ID NO: 1. Also provided are IL-18 variant polypeptide comprising (such as further comprising) at least one mutation at a residue selected from the group consisting of: C38, C68, C76, D98, S117, and C127, wherein the amino acid position is relative to a wild-type human IL-18 set forth in SEQ ID NO: 1. Also provided are IL-18 variant polypeptides bind IL-18Rα and exhibit substantially reduced binding to IL-18BP relative to the wild-type IL-18. Also provided are IL-18 variant polypeptides that exhibit increased binding IL-18Rα relative to the wild-type IL-18 and substantially reduced binding to IL-18BP relative to the wild-type IL-18. Also provided are related nucleic acids, vectors, host cells, methods of producing IL-18 variant polypeptides, pharmaceutical compositions comprising IL-18 variant polypeptides, and uses of such pharmaceutical compositions.

Inventors:
QIANG MIN (CN)
CHEN XI (CN)
WANG ZHENGYI (CN)
ZENG HUI (CN)
ZHENG XIN (CN)
ZHANG FEI (CN)
YUAN PUWEI (CN)
LIU FAN (CN)
Application Number:
PCT/CN2023/117197
Publication Date:
March 14, 2024
Filing Date:
September 06, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
I MAB BIOPHARMA CO LTD (CN)
International Classes:
C07K14/715; A61K38/00; A61P35/00; C07K14/54
Domestic Patent References:
WO2022094473A12022-05-05
WO2021097376A12021-05-20
WO2023161853A12023-08-31
Foreign References:
US20190070262A12019-03-07
CN111315395A2020-06-19
US20050008615A12005-01-13
Attorney, Agent or Firm:
GE CHENG & CO., LTD. (CN)
Download PDF: